Journal Title:Current Hypertension Reviews
Current Hypertension Reviews is an international peer-reviewed journal dedicated to hypertension and its related fields. This journal aims to publish high-quality review articles that integrate the latest clinical findings on the diagnosis, treatment, management, and prevention of hypertension. Through the contributions of international experts, the journal provides a balanced and in-depth perspective to help readers understand the cutting-edge trends in hypertension research. The editorial team of the journal is composed of international authoritative individuals who serve as section editors in key research areas of hypertension, responsible for selecting important topics and inviting leading experts to write review articles. These articles emphasize new research progress and recently published important papers, highlighted through annotated reference lists. In addition, the International Editorial Committee reviews the annual catalog to ensure its timeliness and inclusion of emerging research.
The magazine's articles not only cover traditional topics such as antihypertensive treatment, related metabolic disorders, and treatment trials, but also extend to nephrology, clinical nursing, and other related fields. The target readers of this magazine include clinical doctors, researchers, scholars in the field of hypertension, as well as healthcare professionals interested in hypertension management.
《當(dāng)前高血壓評(píng)論》是一本專注于高血壓及其相關(guān)領(lǐng)域的國(guó)際同行評(píng)審期刊。該雜志旨在發(fā)表高質(zhì)量的綜述文章,這些文章綜合了最新的臨床發(fā)現(xiàn),涉及高血壓的診斷、治療、管理和預(yù)防。通過國(guó)際專家的貢獻(xiàn),期刊提供了平衡且深入的視角,幫助讀者了解高血壓研究的前沿動(dòng)態(tài)。期刊的編輯團(tuán)隊(duì)由國(guó)際權(quán)威人士組成,他們?cè)诟哐獕旱年P(guān)鍵研究領(lǐng)域擔(dān)任版塊編輯,負(fù)責(zé)挑選重要話題,并邀請(qǐng)領(lǐng)先專家撰寫綜述文章。這些文章強(qiáng)調(diào)新的研究進(jìn)展和近期發(fā)表的重要論文,通過注釋參考文獻(xiàn)列表進(jìn)行突出顯示。此外,國(guó)際編輯委員會(huì)審核年度目錄,確保內(nèi)容的時(shí)效性和包含新興研究。
雜志的文章不僅涵蓋了抗高血壓治療、相關(guān)代謝紊亂和治療試驗(yàn)等傳統(tǒng)主題,還擴(kuò)展到了腎臟學(xué)、臨床護(hù)理和其他相關(guān)領(lǐng)域。該雜志的目標(biāo)讀者包括高血壓領(lǐng)域的臨床醫(yī)生、研究人員、學(xué)者以及對(duì)高血壓管理感興趣的醫(yī)療保健專業(yè)人士。
Current Hypertension Reviews由Bentham出版商出版,收稿方向涵蓋PERIPHERAL VASCULAR DISEASE全領(lǐng)域,平均審稿速度 ,影響因子指數(shù)1.5,該期刊近期沒有被列入國(guó)際期刊預(yù)警名單,廣大學(xué)者值得一試。
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:PERIPHERAL VASCULAR DISEASE | ESCI | Q3 | 67 / 96 |
30.7% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:PERIPHERAL VASCULAR DISEASE | ESCI | Q3 | 70 / 96 |
27.6% |
名詞解釋:
WOS即Web of Science,是全球獲取學(xué)術(shù)信息的重要數(shù)據(jù)庫,Web of Science包括自然科學(xué)、社會(huì)科學(xué)、藝術(shù)與人文領(lǐng)域的信息,來自全世界近9,000種最負(fù)盛名的高影響力研究期刊及12,000多種學(xué)術(shù)會(huì)議多學(xué)科內(nèi)容。給期刊分區(qū)時(shí)會(huì)按照某一個(gè)學(xué)科領(lǐng)域劃分,根據(jù)這一學(xué)科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會(huì)在高分區(qū)中,最后的劃分結(jié)果分別是Q1,Q2,Q3,Q4,Q1代表質(zhì)量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||
4.8 | 0.598 | 0.792 |
|
名詞解釋:
CiteScore:衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)。
SJR:SCImago 期刊等級(jí)衡量經(jīng)過加權(quán)后的期刊受引用次數(shù)。引用次數(shù)的加權(quán)值由施引期刊的學(xué)科領(lǐng)域和聲望 (SJR) 決定。
SNIP:每篇文章中來源出版物的標(biāo)準(zhǔn)化影響將實(shí)際受引用情況對(duì)照期刊所屬學(xué)科領(lǐng)域中預(yù)期的受引用情況進(jìn)行衡量。
是否OA開放訪問: | h-index: | 年文章數(shù): |
未開放 | -- | 19 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
1.37% | 1.5 | |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國(guó)際期刊預(yù)警名單(試行)》名單: |
52.63% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商。